Code of Maryland Regulations
Title 10 - MARYLAND DEPARTMENT OF HEALTH
Part 3
Subtitle 10 - LABORATORIES
Chapter 10.10.13 - Medical Laboratories - Testing for Hereditary and Congenital Disorders in Newborn Infants
Section 10.10.13.23 - Reporting Test Results

Universal Citation: MD Code Reg 10.10.13.23

Current through Register Vol. 51, No. 19, September 20, 2024

A. All Test Results. For a newborn infant, a permittee shall:

(1) Report all first-tier, supplemental, and second-tier results to:
(a) The person who requested the test; and

(b) An individual who will use the test results in identifying, tracking, caring for, and treating the newborn infant, including:
(i) A physician specialist; and

(ii) Personnel in the Follow-Up Unit;

(2) Report to the persons listed in §A(1) of this regulation within 3 working days after the laboratory obtains the blood-spot specimen, all test results that are within normal limits;

(3) Report to a person requesting a second or subsequent screening the test results from the newborn infant's prior screening if not previously reported to the person;

(4) Include with each report the following information:
(a) Date the blood-spot specimen was received in the laboratory;

(b) Date of the report; and

(c) Cut-off level for each reported analyte; and

(5) Report all abnormal test results to the Follow-Up Unit on the same day that a test result is obtained and reviewed.

B. Specific Test results. A permittee may not report a test result as being within normal limits for:

(1) Amino acid levels for disorders specified in Regulation .12C(11)-(24) of this chapter and for a total galactose level for galactosemia as specified in Regulation .12C(3) of this chapter if:
(a) A newborn infant was not on milk or formula feeding at least 24 hours before the blood-spot specimen was collected; or

(b) The time of milk or formula feeding is unknown; or

(2) 17-hydroxy progesterone results for congenital adrenal hyperplasia as specified in Regulation .12C(2) of this chapter and thyroxine and thyroid stimulating hormone for hypothyroidism as specified in Regulation .12C(4) of this chapter if the blood-spot specimen was collected when the newborn infant was:
(a) Younger than 24 hours old; or

(b) Of unknown age.

Disclaimer: These regulations may not be the most recent version. Maryland may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.